Search

Author/Creator Storek, Jan

1. Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study. Issue 5 (31st July 2019)

Authors:
Naik, Seema; Riches, Marcie; Hari, Parameswaran; Kim, Soyoung; Chen, Min; Bachier, Carlos; Shaughnessy, Paul; Hill, Joshua; Ljungman, Per; Battiwalla, Minoo; Chhabra, Saurabh; Daly, Andrew; Storek, Jan; Ustun, Celalettin; Diaz, Miguel Angel; Cerny, Jan; Beitinjaneh, Amer; Yared, Jean; Brown, Vale...
Journal:
Transplant infectious disease
Issue:
Volume 21:Issue 5(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. (2nd February 2022)

Authors:
Shah, Ankoor; Storek, Jan; Woolson, Rob; Pinckney, Ashley; Keyes-Elstein, Lynnette; Wallace, Paul K; Sempowski, Gregory D; McSweeney, Peter; Mayes, Maureen D; Crofford, Leslie; Csuka, M E; Phillips, Kristine; Khanna, Dinesh; Simms, Robert; Ballen, Karen; LeClercq, Sharon; Clair, William St; Nixon...
Journal:
Rheumatology
Issue:
Volume 61:Number 10(2022)
Page Start:
4155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant. Issue 8 (2nd June 2022)

Authors:
Kwan, Alex Chi Fung; Blosser, Nikki; Ghosh, Sunita; Leyshon, Catherine; Dersch‐Mills, Deonne; Puckrin, Robert; Duggan, Peter; Zepeda, Victor; Savoie, Lynn; Stewart, Douglas; Storek, Jan; Jamani, Kareem
Journal:
Clinical transplantation
Issue:
Volume 36:Issue 8(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. MS4A4A: a novel cell surface marker for M2 macrophages and plasma cells. Issue 7 (11th April 2017)

Authors:
Sanyal, Ratna; Polyak, Maria J; Zuccolo, Jonathan; Puri, Mandip; Deng, Lili; Roberts, Luc; Zuba, Ania; Storek, Jan; Luider, Joanne M; Sundberg, Ellen M; Mansoor, Adnan; Baigorri, Eva; Chu, Michael P; Belch, Andrew R; Pilarski, Linda M; Deans, Julie P
Journal:
Immunology and cell biology
Issue:
Volume 95:Issue 7(2017)
Page Start:
611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin. Issue 9 (4th July 2020)

Authors:
Ousia, Samar; Kalra, Amit; Williamson, Tyler S.; Prokopishyn, Nicole; Dharmani‐Khan, Poonam; Khan, Faisal M.; Jimenez‐Zepeda, Victor; Jamani, Kareem; Duggan, Peter R.; Daly, Andrew; Russell, James A.; Storek, Jan
Journal:
Clinical transplantation
Issue:
Volume 34:Issue 9(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Risk factors for post‐transplant lymphoproliferative disorder after Thymoglobulin‐conditioned hematopoietic cell transplantation. Issue 1 (1st December 2017)

Authors:
Kalra, Amit; Roessner, Cameron; Jupp, Jennifer; Williamson, Tyler; Tellier, Raymond; Chaudhry, Ahsan; Khan, Faisal; Taparia, Minakshi; Jimenez‐Zepeda, Victor H.; Stewart, Douglas A.; Daly, Andrew; Storek, Jan
Journal:
Clinical transplantation
Issue:
Volume 32:Issue 1(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗